Teva Pharma (TEVA) Tops Q1 EPS by 4c, Revenues Miss; Offers FY21 EPS/Revenue Guidance

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 6/23/2026

1. ABBV
2. MU
3. ACN
4. IBM
5. DPZ
6. PRIM
7. META
8. N2EW34
9. INTC
10. IMNN

Go back to Teva Pharma (TEVA) Tops Q1 EPS by 4c, Revenues Miss; Offers FY21 EPS/Revenue Guidance

Teva Pharma (TEVA) PT Lowered to $12 at Argus

April 26, 2021 7:31 AM EDT

Argus analyst Jasper Hellweg lowered the price target on Teva Pharma (NYSE: TEVA) to $12.00 (from $15.00) while maintaining a Buy rating.... More